Estrogen-progesterone therapy for recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia.

Abstract

Recurrent gastrointestinal bleeding ceased after the institution of estrogen-progesterone therapy in a patient with gastrointestinal angiodysplasia without chronic renal failure. The patient did have aortic stenosis and mitral insufficiency murmurs. A therapeutic trial of conjugated estrogen should be considered in patients with recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia after the use of therapeutic endoscopy and/or surgery.

• Authors: R Granieri, J P Mazzulla, G W Yarborough
• Journal: The American journal of gastroenterology (Am J Gastroenterol) Vol. 83 Issue 5 Pg. 556-8 (May 1988) ISSN: 0002-9270 [Print] United States
• PMID: 3259072 (Publication Type: Case Reports, Journal Article)

Chemical References

• Contraceptives, Oral, Combined
• Infecundin
• Norethynodrel
• Mestranol

Topics

• Aged
• Blood Vessels (abnormalities)
• Contraceptives, Oral, Combined (therapeutic use)
• Digestive System (blood supply)
• Female
• Gastrointestinal Hemorrhage (drug therapy, etiology)
• Humans
• Mestranol (therapeutic use)
• Norethynodrel (therapeutic use)
• Recurrence